NEWER BETA-BLOCKERS AND THE TREATMENT OF HYPERTENSION

被引：13

作者：

MCAREAVEY, D

VERMEULEN, R

ROBERTSON, JIS

机构：

[1] Department of Cardiology, Royal Infirmary, Edinburgh

[2] Janssen Research Foundation, Beerse

[3] Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1991年 / 5卷 / 03期

关键词：

ARTERIAL COMPLIANCE; BLOOD LIPIDS; CARDIAC HYPERTROPHY; CARDIAC OUTPUT; QUALITY OF LIFE;

D O I：

10.1007/BF03029727

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Beta-adrenoceptor blocking agents are established as one of the principal classes of antihypertensive agents. Despite progressive refinements over the years, they still possess some unwanted effects, which limit their considerable value. In recent years a wide range of variations upon the beta-blocker theme has been developed. The full clinical advantages of the newer agents remain to be defined.

引用

页码：577 / 587

页数：11

共 118 条

[101]

Fitzgerald J.D., Age-related effects of beta-blockers and hypertension, Journal of Cardiovascular Pharmacology, 12, 8, pp. 83-93, (1988)

[102]

Murray G.D., Lesaffre E., Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy, Journal of Cardiovascular Pharmacology, 12, 8, pp. 167-172, (1988)

[103]

Murray G.D., Lesaffre E., Robertson J.I.S., Intepreting agerelated aspects of antihypertensive treatment: Statistical defects and their remedy, J Hypertens, 6, 1, pp. 121-126, (1988)

[104]

Staiger C.H., Steger W., Widmann L., Et al., Double-blind controlled clinical trial to evaluate the anti-hypertensive effect of carvedilol in elderly patients with mild to moderate hypertension, Drugs, 36, 6, pp. 169-171, (1988)

[105]

Hitzenberger G., Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients, Br J Clin Prac, 39, pp. 25-32, (1985)

[106]

Hoffmann W., Hoffmann H., Results of the Austrian celiprolol postmarketing surveillance study, Journal of Cardiovascular Pharmacology, 8, 4, pp. 88-90, (1986)

[107]

Norris R.J., Lee E.H., Muirhead D., Sanders S.W., A pharmacokinetic evaluation of celiprolol in healthy elderly volunteers, J Cardiovasc Pharmacol, 8, 4, pp. 91-93, (1986)

[108]

Andersson O., Hedner T., Nyberg G., Acute and long term antihypertensive effect of bopindolol once daily or once weekly, Journal of Cardiovascular Pharmacology, 8, 6, pp. 74-76, (1986)

[109]

Weidmann P., Bousquet J-C, Antihypertensive treatment with bopindolol alone or controlled with a diuretic in general practice, Journal of Cardiovascular Pharmacology, 8, 6, pp. 80-87, (1986)

[110]

Wallin J.D., Cook E., Clifton G.G., Et al., Effects of the R-R optical isomer of labetalol in patients with severe hypertension, Arch Intern Med, 148, pp. 534-538, (1988)

← 3 4 5 6 7 8 9 10 11 12 →